Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Original Article
Author Details :
Volume : 3, Issue : 4, Year : 2016
Article Page : 221-224
Abstract
A simple, validated, accurate and precise simultaneous UV Spectrophotometric method has been developed for the simultaneous estimation of Telmisartan (TEM) and Ramipril (RAM) in pharmaceutical dosage form. Telmisartan exhibits absorption maximum at 254.4nm and Ramipril shows absorption maximum at 209nm in methanol. The Beer’s law obeyed the concentration range of 2-12µg/ml for both TEM and RAM. Mean recovery of 99.14% for TEM and 99.05% for RAM respectively signifies the accuracy of the method. The method was validated as per ICH guidelines. The method shows good linearity, accuracy, precision, limit of detection and limit of quantification. This method can be successfully employed for the routine simultaneous estimation of TEM and RAM in pharmaceutical dosage forms.
Keywords: Telmisartan, Ramipril, Estimation, Spectrophotometry, Dosage form
How to cite : Lakshmana Rao A, Prasanthi T, Anusha J, Prasanna Mr, Jyothi P, Method development and validation for simultaneous determination of Telmisartan and Ramipril by UV Spectrophotometry. Indian J Pharm Pharmacol 2016;3(4):221-224
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.